Crossmark

EBM BLS: Varenicline Improves Electronic Cigarette Quit Success Rate

Crossref DOI link: https://doi.org/10.1007/s11606-025-09370-4

Published Online: 2025-02-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Krienke, Mary

Fuest, Stephen https://orcid.org/0000-0001-5517-695X
License Information

Text and Data Mining valid from 2025-02-27

Version of Record valid from 2025-02-27
More Information

Article History

Received: 7 October 2024

Accepted: 30 December 2024

First Online: 27 February 2025

Declarations:

: None

: None for any of the study authors.